MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,286 | -1.8% | 6,829 | +22.1% | 0.00% | – |
| Q2 2023 | $69,503 | -99.7% | 5,592 | -99.7% | 0.00% | -100.0% |
| Q1 2023 | $27,270,610 | +1910.7% | 1,946,510 | +1953.7% | 0.00% | – |
| Q4 2022 | $1,356,290 | -97.9% | 94,779 | -96.3% | 0.00% | -100.0% |
| Q3 2022 | $64,532,000 | -43.3% | 2,527,679 | -36.9% | 0.01% | -36.4% |
| Q2 2022 | $113,865,000 | -65.8% | 4,007,903 | -57.5% | 0.01% | -59.3% |
| Q1 2022 | $332,948,000 | -37.5% | 9,439,990 | -25.7% | 0.03% | -30.8% |
| Q4 2021 | $532,450,000 | -39.4% | 12,707,646 | -29.0% | 0.04% | -44.3% |
| Q3 2021 | $877,909,000 | +66.3% | 17,887,296 | +41.4% | 0.07% | +70.7% |
| Q2 2021 | $527,980,000 | +52.7% | 12,652,271 | +30.4% | 0.04% | +36.7% |
| Q1 2021 | $345,824,000 | +116.0% | 9,703,243 | +70.0% | 0.03% | +114.3% |
| Q4 2020 | $160,069,000 | – | 5,706,562 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |